You have 9 free searches left this month | for more free features.

exemestane

Showing 26 - 50 of 158

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)

Completed
  • Metastatic Breast Cancer
  • Chuo-ku, Nihonbashi, Koami-cho, Tokyo, Japan
    Japan Breast Cancer Research Group
Aug 2, 2022

Breast Cancer Trial in Baltimore (Tamoxifen Citrate, Letrozole, Exemestane)

Recruiting
  • Breast Cancer
  • Tamoxifen Citrate
  • +4 more
  • Baltimore, Maryland
    Johns Hopkins Bayview Hospital
Nov 30, 2021

Breast Cancer Trial in Worldwide (ribociclib (LEE011), Exemestane, Everolimus (RAD001))

Completed
  • Breast Cancer
  • ribociclib (LEE011)
  • +2 more
  • Fayetteville, Arkansas
  • +12 more
Apr 8, 2021

Breast Cancer Trial in Duarte, South Pasadena (drug, other, procedure)

Completed
  • Breast Cancer
  • exemestane
  • +3 more
  • Duarte, California
  • +1 more
Sep 23, 2020

Breast Cancer Metastatic Trial in Ravensburg (Ribociclib, Anastrozole, Letrozole)

Active, not recruiting
  • Breast Cancer Metastatic
  • Ravensburg, Germany
    Studienzentrum Onkologie Ravensburg
Mar 7, 2022

Solid Tumors and Lymphomas Trial in United States (Alobresib, Exemestane, Fulvestrant)

Completed
  • Solid Tumors and Lymphomas
  • Scottsdale, Arizona
  • +3 more
Dec 2, 2020

Sequence in HR+, HER2 - mBC in Moscow: A Multicenter

Recruiting
  • Breast Cancer Stage IV
  • Moscow, Russian Federation
    N.N. Blokhin National Medical Research Center of Oncology
Apr 15, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Anastrozole,

Active, not recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Atlanta, Georgia
  • +9 more
Oct 12, 2022

Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)

Recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +10 more
Nov 11, 2022

Breast Cancer, Invasive Breast Cancer Trial in Milwaukee (Anastrozole, Letrozole, Exemestane)

Active, not recruiting
  • Breast Cancer
  • Invasive Breast Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital
Sep 16, 2021

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Breast Cancer Trial in Guangzhou (Tucidinostat, Exemestane, Ovarian function suppression)

Unknown status
  • Breast Cancer
  • Guangzhou, Guangdong, China
    The first affiliated hospital of Sun Yat-Sen university
Jul 22, 2020

Metastatic Breast Cancer Trial in Houston (Exemestane, Sutent)

Terminated
  • Metastatic Breast Cancer
  • Houston, Texas
    Baylor College of Medicine, Lester and Sue Smith Breast Center
Jul 9, 2020

ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant

Recruiting
  • ER+ Breast Cancer
  • HER2-negative Breast Cancer
  • Palbociclib 125Mg Tab
  • +5 more
  • Christchurch, United Kingdom
  • +3 more
May 19, 2022

Advanced or Recurrent Breast Cancer Trial in Japan (Entinostat, Entinostat(Placebo), Exemestane)

Completed
  • Advanced or Recurrent Breast Cancer
  • Nagoya, Aichi, Japan
  • +27 more
Jun 15, 2022

Breast Cancer Trial in Houston (Everolimus, Exemestane, Metformin)

Terminated
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 5, 2020

Breast Tumor Trial in Mainz (Palbociclib, Fulvestrant, Anastrozole)

Terminated
  • Breast Neoplasm
  • Mainz, Germany
    University Hospital Mainz
Dec 16, 2021

Tumors, Breast Tumors, Kidney Tumors Trial in Worldwide (alpelisib, everolimus, exemestane)

Completed
  • Neoplasms
  • +3 more
  • Fayetteville, Arkansas
  • +21 more
Dec 4, 2020

Breast Cancer Trial in United States (Ribociclib, Everolimus, Exemestane)

Completed
  • Breast Cancer
  • Chandler, Arizona
  • +24 more
Apr 10, 2021

Breast Cancer Trial in Spain (Alpelisib, Metformin, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Alicante, Spain
  • +17 more
Aug 23, 2022

Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +132 more
Apr 26, 2022

Breast Cancer Trial in Belgium, France, United States (Sapanisertib, Fulvestrant, Exemestane)

Completed
  • Breast Cancer
  • Los Angeles, California
  • +39 more
Dec 16, 2020

Estrogen-receptor Positive Invasive Metastatic Breast Cancer Trial in Philadelphia (Ruxolitinib, Exemestane)

Completed
  • Estrogen-receptor Positive Invasive Metastatic Breast Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 29, 2020

Metastatic Beast Cancer Trial in New York (Exemestane, Cyclophosphamide)

Completed
  • Metastatic Beast Cancer
  • New York, New York
    NYU Cancer Center
Mar 3, 2020

Breast Cancer Trial in Italy (Epirubicin, Cyclophosphamide, Triptorelin)

Completed
  • Breast Cancer
  • Cona, FE, Italy
  • +4 more
Dec 2, 2020